Ignite Creation Date:
2024-05-06 @ 8:42 AM
Last Modification Date:
2024-10-26 @ 12:04 PM
Study NCT ID:
NCT02801097
Status:
TERMINATED
Last Update Posted:
2022-05-17
First Post:
2016-06-10
Brief Title:
RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer PAYLOAD
Sponsor:
EpicentRx Inc
Organization:
EpicentRx Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-10
First Submit QC Date:
June 10 2016
Study First Post Date:
2016-06-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-12
Last Update Post Date:
2022-05-17
Last Update Post Date Type:
ACTUAL